CYTK
CYTK
NASDAQ · Biotechnology

Cytokinetics Inc

$62.39
+2.37 (+3.95%)
As of Mar 25, 9:48 PM ET ·
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Buy 22 85%
Hold 4 15%
Sell 0 0%
Price Target
Analyst Price Target +27.9% upside
Low Target $53.35
Average Target $79.81
High Target $115.71
Current Price $62.39
Current
$62.39
Target
$79.81
$53.35 $79.81 avg $115.71
Scenario Analysis
Bear Case
$53.35
-14.5%
Low target
Base Case
$79.81
+27.9%
Avg target
Bull Case
$115.71
+85.5%
High target
Risk/Reward
5.9x
Highly favorable
Price in Context
52-Week High
$70.98
-12.1% from high
52-Week Low
$29.31
+112.9% from low
50-Day SMA
$63.59
-1.9% vs SMA
200-Day SMA
$49.97
+24.9% vs SMA
RSI (14)
55.5
Neutral
Target vs 52W High
$79.81
+12.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%